Ecns wire

China's first COVID-19 oral medicine covered by medical insurance

2022-08-15 Editor : Zhang Dongfang ECNS App Download

(ECNS) -- China's first domestic COVID-19 oral medicine Azvudine is now covered by medical insurance.

It has been included in the COVID treatment plan by the National Health Commission since August 9.

All drugs that have been included in the treatment plan can be temporarily paid for by medical insurance, said the National Healthcare Security Administration.

Azvudine, produced by Genuine Biotech Limited, a company based in Henan Province, contains 35 tablets per bottle with one milligram per tablet. Its price was set at less than 300 yuan (about $44.4) per bottle.


Most popular in 24h

MoreTop news


Back to top About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2022 All rights reserved.
Reproduction in whole or in part without permission is prohibited.
[网上传播视听节目许可证(0106168)] [京ICP证040655号]
[京公网安备 11010202009201号] [京ICP备05004340号-1]